Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UFM1 pseudogene 2 (UFM1P2) is a noncoding genomic locus annotated as a pseudogene of ubiquitin fold modifier 1 (UFM1), a ubiquitin-like modifier involved in ufmylation, a post-translational protein modification[3][5]. Unlike functional UFM1, UFM1P2 does not encode a protein and has no documented biological function, disease associations, or therapeutic relevance. The existence of UFM1P2 is not generally associated with clinical, pharmacological, or biomarker research. The functional activities of UFM1 and its pathway—including roles in cellular stress, neurodevelopment, and disease—do not pertain to UFM1P2[1][5]. If searching for a therapeutic target, "UFM1P2" is not appropriate; the relevant target is "ubiquitin fold modifier 1" (UFM1), not its pseudogene. UFM1P2 does not encode a receptor, enzyme, or druggable protein, and entries or research on this locus should be interpreted with caution or redirected to the functional UFM1 gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UFM1 pseudogene 2 (UFM1P2).